AGP Executive Report
Last update: 12 hours agoChina Trade: Switzerland and China have upgraded their free-trade agreement, with zero tariffs planned on more than 99% of imports as Swiss firms deepen their China operations. Pharma: Sandoz cut its sales-growth outlook after supply issues hit biosimilars; Novartis, despite $2.2 billion in trial-related charges, raised its 2026 profit outlook. AI at Work: Proton says it does not track staff use of AI-generated code and says AI reviews will not mean job losses, after criticism of its internal AI push. Banking: UBS reported a 27% rise in third-quarter pre-tax profit as its $3 billion share buyback moves ahead. Retail: Migros plans to merge regional cooperatives amid financial pressure and a scandal. Markets: Swiss shares reached a new record high.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.